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Aim: To identify the symptoms and quality of life impacts that are important from the perspective of 
patients with varicose veins, and to compare identified themes to items in varicose vein Patient 
Reported Outcome Measures (PROMs).  
Background: Varicose veins are common worldwide, and are considered a chronic condition with 
implications for quality of life. Treatment is predominantly conservative, therefore understanding 
patientsげ experienceゲげ of living with varicose veins is important to inform the provision of clinical 
care. PROMs are often used to collect data about ヮ;デｷWﾐデゲげ quality of life.  
Design: Thematic synthesis of qualitative research reported according to ENTREQ guidelines.  
Methods: Multiple electronic databases, including MEDLINE and CINAHL, were systematically 
searched to identify qualitative research examining experiences of adults with varicose veins. 
Thematic synthesis was then conducted on the included studies.  
Results: Three studies met the inclusion criteria; the quality of the studies was high. The range and 
intensity of reported ゲ┞ﾏヮデﾗﾏゲ ;ﾐS ヮ;ヴデｷIｷヮ;ﾐデげゲ W┝ヮWヴｷWﾐIWs of living with varicose veins were 
varied. Five overarching themes were identified; physical, psychological and social impact of varicose 
veins, adapting to varicose veins and reasons for seeking treatment. The overall key theme to 
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Conclusion: This review demonstrates that varicose veins have a wide range of symptoms, and may 
have a significant impact on quality of life; people made significant adaptations to enable them to 
live their lives as fully as possible.  
Relevance to Clinical Practice: Healthcare professionals need to be aware of the range of symptoms, 
and their impact on quality of life. The use of PROMs to gather information about quality of life and 
symptoms is well established globally; however, PROMs currently used may not capture the full 
W┝デWﾐデ ﾗa デｴW ｷﾏヮ;Iデ ﾗﾐ ヮ;デｷWﾐデげゲ ケ┌;ﾉｷデ┞ ﾗa ﾉｷaW.  
Keywords: 
Varicose veins, systematic review, qualitative research, patient reported outcome measures, 
PROMs, quality of life, symptoms. 
 
Summary Points - What does this paper contribute to the wider global clinical community? 
 This review identifies that there are a wide range of symptoms of varicose veins, and 
that symptoms I;ﾐ ｴ;┗W ; ゲｷｪﾐｷaｷI;ﾐデ ｷﾏヮ;Iデ ﾗﾐ ヮ;デｷWﾐデゲげ ケ┌;ﾉｷデ┞ ﾗa ﾉｷaWく Iデ 
demonstrates that patients often adapt their lives in order to cope with the range of 
impacts that their varicose veins have.  
 It highlights that a number of different instruments can be used to measure the 
effects of varicose veins; however, it is clear that no instrument currently captures 
the full impact of varicose veins on quality of life.  
 Healthcare professionals need to ensure patients are fully informed of all aspects of 
their condition in order to help with self-management, increase adherence to 
compression therapy, allay unfounded fears and manage treatment expectations.  
 Familiarity with the findings of existing qualitative literature through qualitative 
reviews, or employment of qualitative research methods such as interviews, enables 
an in-depth understanding of the range and severity of symptoms, and resulting 
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Experiences of living with varicose veins: a systematic review of qualitative research 
INTRODUCTION 
Varicose veins (VV) are a relatively common vascular condition globally with worldwide prevalence 
ranging from 5-15% for men, and 2-29% for women (Health Quality Ontario (HQO) 2011). Vein 
problems are amongst the most common chronic conditions in North America and Western Europe 
(Vascular Disease Foundation 2005). Lower limb VV are estimated to be the 7
th
 most common 
reason for physician referral in the United States (US), affecting an estimated 35% of the US 
population (HQO 2011); VV are also the most prevalent vascular condition treated by physicians in 
Australia (Wong 2017). 
It is estimated that VV affect at least a third of the United Kingdom (UK), (Evans et al 2014) and up to 
40% of the general population (Robertson et al 2016). 
VV are one of a number of symptoms associated with chronic venous insufficiency (CVI) and chronic 
venous disease (CVD).  CVI occurs when the venous wall and/or valves in the leg veins are not 
working effectively, causing blood to collect in the veins. The reflux of blood results in VV which 
become enlarged lumpy and visible, and are usually present in lower limbs.  
VV cause symptoms such as throbbing pain, aching swelling, cramping, itching and bleeding 
(Palfreyman et al 2009); VV associated symptoms, and consequential restrictions on the ability to 
walk and stand, can have a substantial impact on patient quality of life (QoL) (Darvall et al 2012, 
Kahn et al 2004).  
An estimated 30% of people with VV will develop skin changes such as eczema, oedema and skin 
discoloration, associated with CVD (Lee et al 2015). In addition, between 3 and 6% of people with VV 
will progress to developing venous leg ulcers (VLU), another chronic condition associated with CVI, 
(National Institute for Health and Care Excellence (NICE) 2013). Approximately 2% of UK National 
Health Service (NHS) resources are spent on managing venous disease (Shingler et al 2013), with 
35,659 VV procedures carried out in the NHS in 2009/10 alone (NICE 2013). 
VV can be treated conservatively, through the use of compression hosiery and lifestyle advice. 
Compression therapy does not actively treat CVD, it is used to manage symptoms such as swelling, 
heaviness and pain, and to help blood flow and venous return, thus slowing disease progression 
(NICE 2013). Patients should also receive advice regarding weight, lifestyle, measures to prevent 
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However, adherence to treatment can be an issue, and the evidence base for the effectiveness of 
these approaches is limited (Shingler et al 2013). Alternatively, invasive treatments, such as 
endothermal ablation, foam sclerotherapy and surgery, may be required to reduce symptoms and 
slow disease progression.  
Decisions on how, and when, to treat VV are subject to variation across the UK and are based on 
local interpretation of NICE guidance and referral guidelines, by regional clinical commissioning 
groups (CCG) (Lim et al 2010 and Marsden et al 2013). Quality of life (QoL) issues may be deciding 
factors in treatment decisions; therefore, understanding the effect that VVs have on QoL is 
important. 
One method of collecting data about QoL is the use of patient-reported outcome measures 
(PROMs). PROMs comprise of a series of structured questions that ask patients about their health, 
and health-related QoL, from their point of view (Devlin and Appleby 2010). PROMs provide 
information about the impact of a disease, or its associated treatment, from a patientゲげ perspective; 
they do not ask about satisfaction with, or experience of, healthcare services.  
PROMs are used internationally by health organisations both to collect routine data to inform policy 
decisions, and by individual clinicians to gather patient information in order to guide clinical and 
shared decision-making (Black 2013). PROMs are either generic, so they can be used across different 
populations and health conditions, and can allow comparison between groups; or they can be 
disease or condition specific, containing items that are more relevant to that specific group.  
PROMs are used globally, although their use is better established in countries such as the UK, the 
Netherlands, Sweden and the US (Williams et al 2016). In the US the Food and Drug Administration 
(FDA) recommended that PROMs should be included in all clinical trials (FDA 2009).  More recently, 
in 2016, a commission was established in Australia to review the rationale and use of PROMs in 
order to help embed the use of PROMs in the Australian healthcare system (Williams et al 2016).  
Despite the increasing use of PROMs in clinical practice it is important to note that there are 
limitations in their use, dues to issues of validity and reliability related to the nature of self-report. 
Relying on patients to self-report their health can be challenging, particularly with patients suffering 
from cognitive deficits, paralysis or dementia, those who may not read or speak English, or those 
that are not literate (children and babies).  Proxy versions of PROMs (e.g. that can be completed by 
caregivers) and PROMs designed for completion by specific groups, such as children, do exist; 
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contexts (Devlin & Appleby 2010). PROMs data should therefore be seen as complementing, rather 
than replacing, clinical and other information about patients. 
Since 2009 in the UK NHS providers have been required to collect PROMs for four surgical 
procedures, including VV treatment; the other three procedures are hernia repair, and hip and knee 
replacements. Completion of PROMs is voluntary, and patients are under no obligation to take part. 
In 2013-14 PROM completion rates for VV patients was considerably lower than for the other 
procedures; just 40.5% compared with hip and knee surgery at nearly 86% and 94%, and an average 
of 76% across all four procedures (Health and Social Care Information Centre (HSCIC) 2016). There 
does not appear to be any established reason why VV PROM completion rates are so comparatively 
poor, however, one explanation could be that the PROMs being used do not contain items that are 
relevant to VV patients. The NHS currently uses the generic PROM the EQ5D/EQ5D-VAS (EuroQol 
1990) and the condition specific Aberdeen VV Questionnaire (AVVQ) (Garratt et al 1993); to date 
there is no published evidence that the EQ5D has been validated for use with VV patients.   
A recent systematic review (Aber et al 2017) was conducted to identify PROMs that have undergone 
some kind of published validation for use with VV patients, and assess their psychometric properties. 
Three disease-specific PROMs; the AVVQ (Garrett et al 1993), VV Symptom Questionnaire (VVSymQ) 
(Paty et al 2015), Specific QoL Outcome Response-Venous (SQOR-V) (Guex et al 2007), and one 
generic PROM, the Short-Form 36 (SF-36) (Ware et al 1992) were identified. The review concluded 
that based on its psychometric properties the AVVQ was the most appropriate disease specific 
instrument, with evidence of construct validity, test-retest reliability and responsiveness but less 
evidence for content validity and acceptability. An example of the questions from the AVVQ can be 
seen in appendix one. The SF-36 was the most suitable generic PROM, for use with patients with VV 
with satisfactory responsiveness and acceptability, but with limited assessment of other 
psychometric properties.  
C┌ヴヴWﾐデﾉ┞ NICE VV ｪ┌ｷS;ﾐIW ゲ┌ｪｪWゲデゲ デｴ;デ けQ┌;ﾉｷデ┞-of-life measures are unlikely to reflect severity of 
SｷゲW;ゲW HWI;┌ゲW ﾗa ┗;ヴｷ;デｷﾗﾐゲ ｷﾐ ヮWヴIWヮデｷﾗﾐ ﾗa ゲ┞ﾏヮデﾗﾏゲげ ふNICE ヲヰヱンぶき デｴWヴWaﾗヴW, it is necessary to 
assess whether these existing PROMs actually reflect the symptoms and issues that are most 
relevant to patients.  
Content validity of PROMs is the extent to which items on a test are representative of what is 
intended to be measured. Content validity when developing PROMs can be enhanced by using 
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relevant to the patient group, and using these findings to develop the items incorporated into the 
PROM. 
Whether used in clinical practice, or as a research tool, PROMs should be rigorously developed to 
ensure that they adequately represent, and capture, the experiences of the population they are to 
be used with.  
QoL is central to the individual patientげs experience of health and disease; measures of QoL must do 
ﾏﾗヴW デｴ;ﾐ SWゲIヴｷHW ; ヮ;デｷWﾐデげゲ ｴW;ﾉデｴ ｷﾐ デWヴﾏゲ ﾗa ┘ｴ;デ ｴW;ﾉデｴ ヮヴﾗaWゲゲｷﾗﾐ;ﾉゲ ;ﾐS ゲﾗIｷWデ┞ HWﾉｷW┗W 
constitutes health (Carr et al 2001). The measurement of improvements, or otherwise, in QoL 
associated with patient centred care should preferably be performed using PROMs that have been 
constructed with the involvement of those experiencing the health state. 
This qualitative evidence synthesis is related to the identification and evaluation of existing condition 
specific or generic PROMs that have been validated for use in populations with vascular conditions. 
The synthesis is also an integral part of the development of a new PROM, specifically an electronic 
patient questionnaire (ePAQ-VAS) for use in this population. The review complements a series of 
other projects undertaken as part of a National Institute for Health Research (NIHR) Programme 
Grant に The Vascular Programme Grant (VPG) Project ID: RP-PG-1210-12009) (Michaels et al 2014) 
which has the aim of evaluating vascular services and making recommendations regarding patient-
focused care. Programme work-streams include:  
 Similar reviews of qualitative evidence of four other vascular conditions, (abdominal aortic 
aneurysm (AAA), carotid artery disease (CAD), peripheral arterial disease (PAD) and venous 
leg ulcers (VLU)) 
 Five systematic reviews identifying and evaluating PROMs used by patients with five vascular 
conditions (AAA, CAD, PAD, VLU and VV) 
 Primary qualitative research into the experience of living with these five vascular conditions. 
Aims 
1. The primary aim of this qualitative evidence synthesis was to examine the symptoms and 
QoL domains that are important from the perspective of patients with varicose veins.  
2. A secondary aim was to compare the themes identified in the synthesis to items in PROMs 
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METHODS 
This systematic review was conducted using explicit, systematic methods to reduce the risk of bias 
and provide reliable findings in accordance with published guidelines (Higgins et al 2011); 
specifically, a thematic synthesis was conducted as this is a recognised method used in systematic 
reviews of qualitative research which preserves an explicit and transparent link between review 
conclusions and the primary research (Thomas et al 2008). This review follows the design established 
in a pre-published protocol (Duncan et al 2016) titled; けUnderstanding the experience and impact of 
living with a vascular condition from the ヮ;デｷWﾐデゲげ perspectiveげ; and is reported according to the 
けEﾐｴ;ﾐIｷﾐｪ Tヴ;ﾐゲヮ;ヴWﾐI┞ ｷﾐ ‘Wヮﾗヴデｷﾐｪ デｴW S┞ﾐデｴWゲｷゲ ﾗa Q┌;ﾉｷデ;デｷ┗W ‘WゲW;ヴIｴげ (ENTREQ) statement 
(Tong et al 2012). The ENTREQ checklist can be seen in the supplementary file 1. 
 
Study Identification and Selection 
Studies were included if they were primary, qualitative research studies including populations of 
adults with VV, and published in English. Mixed-methods studies, where details of data collection, 
analyses and results of the qualitative portion of the study were reported separately, were included. 
Appendix two shows the eligibility criteria. 
Searches were conducted in Cinahl, Embase, Medline, PsycINFO, Science Citation Index and the 
Social Science Citation Index, and ProQuest dissertations and theses. No language or date 
restrictions were applied as an initial scoping search had identified a lack of available literature in 
this subject area. Additionally, reference lists of included studies and related reviews were 
scrutinised, and citation searches were conducted (see appendix three for full details of the search 
strategy). 
Two reviewers (EL, PP) independently screened the title and abstract of all studies identified by the 
searches, with reference to the inclusion and exclusion criteria in the published protocol. All 
potential full text papers were read, and discussion was used to resolve any difference of opinion. A 
third researcher (AA) was available for consultation if consensus could not be reached.  
 
Data Extraction and Quality Assessment 
Data extraction was conducted using a study specific data extraction form, details of author; date; 
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diagnosis and eligibility criteria were collected (appendix four). The Critical Appraisal Skills 
Programme (CASP) qualitative research checklist was employed to assess the methodological quality 
of the included papers, including trustworthiness and relevance (CASP 1998). The CASP checklist was 
chosen as it assesses both the appropriateness and quality of reporting, and is commonly used in 
qualitative reviews of evidence (Caroll & Booth 2014). The checklist comprises of ten questions 
about the qualitative methodology and are answered WｷデｴWヴ け┞Wゲげが けﾐﾗげ ﾗヴ け┌ﾐIﾉW;ヴげく  Quality 
assessment was conducted independently by two researchers (EL, PP) and any discrepancies were 
resolved through discussion following the CASP criteria. 
 
Data Analysis 
Each full text paper was uploaded electronically into NVIVO 10 (QSR International, Burlington, USA), 
the reviewers read through each of the papers to familiarise themselves with the study and results, 
the results sections were then analysed using thematic synthesis (Thomas & Harden 2008).  
Inter-observer agreement of coding was checked and consensus was high; showing substantial, 
almost perfect or perfect agreement with kappa coefficient rating commonly between 0.61-1 (Viera 
& Garrett 2005).  
A provisional thematic framework (appendix five) was developed using conceptual domains from 
PROMs validated for use with VV patients (appendix six), that were identified in a separate review 
(Aber et al 2017).  
Initial coding of the text was conducted independently line-by-line with relevant sections and 
quotations highlighted and assigned to the specific nodes of the provisional thematic framework. 
There was the potential to constrain or limit the deduction of new themes by using a preliminary 
framework however, it did not pre-determine the final themes.  
Comparisons were made across the three included studies matching emergent themes to those 
already established in the framework. Where new concepts were identified additional themes were 
created and previously coded papers were re-visited to establish if any aspects of their findings 
matched the newly created theme. The classification of text according to existing and emergent 
themes is comparable to the development of descriptive themes in thematic analysis (Thomas & 
Harden 2008) ┘ｴWヴW デｴWﾏWゲ ヴWﾏ;ｷﾐ けIﾉﾗゲW デﾗ デｴW ヮヴｷﾏ;ヴ┞ ゲデ┌S┞げく  Figure one demonstrates the 
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Results 
A total of 1804 references were identified, following the removal of duplicates 1318 citations were 
screened, of these 56 full text articles were retrieved and screened for eligibility of these 53 were 
excluded. Reasons for exclusion were: the paper was not available in English, the study population 
was not clearly defined solely as VV, or the study was not qualitative research, or did not detail data 
collection or analysis methods. Study selection is detailed in the PRISMA Flow Diagram (Figure two) 
Three independent studies that met the inclusion criteria were identified (table one). The studies 
were published between 2004 and 2016 and were conducted in Sweden (n=1), and the UK (n=2).  
Quality Assessment 
The overall quality of the included studies was high with positive responses for most items on the 
CASP checklist (appendix seven). Positive responses indicate that the paper has met the relevant 
CASP criteria for credibility and rigour. However, two of the three studies did not fully consider that 
the relationship between the researcher and study participants, therefore potentially introducing 
bias into the research process. Studies were not excluded or weighted based on quality.  
 
THEMES 
Five overarching themes were identified; physical impact of VV, psychological impact, social impact, 
adapting to VV and reasons for seeking treatment. Within these main themes further sub-themes 
were identified: symptoms, symptom management, physical function, worry/anxiety, appearance, 
social restrictions and relationships (table two). 
Physical Impact 
The physical impact of VV was evident across all three included papers, as were the sub-themes of 
symptoms, management of symptoms and physical function. 
Symptoms 
Descriptions of pain, heaviness and itching were common to participants in all three studies with 
swelling reported in only two papers. Cramps, tingling and numbness were also reported as 
troublesome symptoms (Franz & Wann-Hansson 2015), reflecting the broad range of physical 
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of life, such as sleep, resulting in participants feeling tired. The distress associated with symptoms is 
clearly described by some study participants, whilst for others the symptoms were less troubling.  
さTｴW┞ Sヴｷ┗W ﾏW ﾏ;Sが ;Hゲﾗﾉ┌デWﾉ┞ ﾏ;S ┘ｷデｴ デｴW ｷデIｴｷﾐｪく Iげﾉﾉ ゲcratch them and scratch them that much 
デｴ;デ I ﾏ;ﾆW デｴWﾏ ﾉｷﾆWが ┞ﾗ┌ ﾆﾐﾗ┘ ゲIヴ;デIｴ ﾏ;ヴﾆゲが I ﾏ;ﾆW デｴWﾏ HﾉWWS ┘ｷデｴ デｴW ゲIヴ;デIｴ ﾏ;ヴﾆゲくざ 
Participant 13 に Palfreyman et al 
さIデ ┌ゲWS デﾗ ;aaWIデ W┗Wヴ┞デｴｷﾐｪ I ┘ﾗ┌ﾉS Sﾗが W┗Wヴ┞ S;┞ぐくくｷデ ┘;ゲ ヴW;ﾉﾉ┞ ;┘a┌ﾉぐくﾏ┞ ﾉWｪゲ ┘WヴW ゲﾗ ゲﾗre and 
┌ﾐIﾗﾏaﾗヴデ;HﾉWくざ Patient 14 に Hudson et al 
さTｴW┞ ┘WヴWﾐげデ ヮ;ｷﾐa┌ﾉ W┝;Iデﾉ┞が H┌デ Wヴﾏ ;デ デｴW WﾐS ﾗa デｴW S;┞ I ┘ﾗ┌ﾉS HW IﾗﾐゲIｷﾗ┌ゲ ﾗa デｴWﾏが ﾉｷﾆW デｴW┞ 
┘WヴW ;Iｴ┞が ┞ﾗ┌ ﾆﾐﾗ┘が ﾐﾗデ ヮ;ｷﾐa┌ﾉざ Patient 9 に Hudson et al 
 
Management of Symptoms 
All three papers contained descriptions of how participants used different strategies to manage the 
impact of their symptoms. The main coping strategies employed were elevation of legs and the use 
of creams, ointments and compression hosiery. However, where these strategies were ineffective, 
or inappropriate, individuals called upon their own internal resources.  
The use of compression hosiery was viewed differently in the two studies that comment; Franz and 
Wann Hansen, while acknowledging the difficulties involved in wearing compression hosiery, report 
benefits in reducing swelling and suggest, and that for some individuals, the use of stockings is 
crucial to getting everyday work done. In contrast Palfreyman et al report a widespread 
dissatisfaction with the use of compression hosiery by patients, which to some extent seemed to be 
shared by clinicians. 
さTｴW SﾗIデﾗヴ ふ;デ デｴW ﾗ┌デヮ;デｷWﾐデ IﾉｷﾐｷIぶ ;ゲﾆWS ｷa I ┌ゲWS ゲデﾗIﾆｷﾐｪゲく I ゲ;ｷS デｴW┞げヴW ; ┘;ゲデW ﾗa デｷﾏWく HW ゲ;┞ゲ 
けYﾗ┌ デｴｷﾐﾆ ゲﾗい Iげﾏ ｷﾐIﾉｷﾐWS デﾗ ;ｪヴWW ┘ｷげ デｴ;デげくざ Participant 1 に Palfreyman et al 
Palfreyman et al also noted the use of analgesia to manage pain and discomfort, with one 
participant describing the use of a range of non-steroidal anti-inflammatories (NSAIDs) with varying 
effects and another participant using paracetamol/ codeine combinations. 
TｴW ﾏ;ﾐ;ｪWﾏWﾐデ ﾗa ゲ┞ﾏヮデﾗﾏゲ デｴWﾏW ｷゲ SｷヴWIデﾉ┞ ﾉｷﾐﾆWS デﾗ デｴW けAS;ヮデｷﾐｪ デﾗ VVげ デｴWﾏW ;ゲ ;ﾉﾉ デｴヴWW 
papers report how participants make life adaptations, as well as practical ones to relieve symptoms, 
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さTｴW ﾉ;ゲデ aW┘ S;┞ゲ I ﾉｷデWヴ;ﾉﾉ┞ Iヴ;┘ﾉWS デｴヴﾗ┌ｪｴ デｴW Sﾗﾗヴ ;ﾐS ｴ;S デﾗ ゲｷデ Sﾗ┘ﾐ ┘ｷデｴ ﾏ┞ aWWデ ┌ヮ ｴｷｪｴ デﾗ 
ｪWデ デｴW HﾉﾗﾗS ;ﾐS ゲ┘Wﾉﾉｷﾐｪ Sﾗ┘ﾐくざ  Patient 14 に Hudson et al 
さI ヮ┌デ IヴW;ﾏ ﾗﾐが ┞ﾗ┌ ﾆﾐﾗ┘ ゲﾗﾗデｴｷﾐｪ Iヴeam like calamine and stuff like that and that voltarol gel, 
デｴ;デげゲ ケ┌ｷデW ｪﾗﾗSくざ  Participant 5 にPalfreyman et al 
さI aWWﾉ デｴ;デ デｴW ﾉWｪ HWIﾗﾏWゲ ; ﾉｷデデﾉW ﾏﾗヴW ゲ┘ﾗﾉﾉWﾐ ┘ｴWﾐ I Sﾗﾐげデ ｴ;┗W デｴW ゲデﾗIﾆｷﾐｪゲ ﾗﾐが WゲヮWIｷ;ﾉﾉ┞ Sﾗ┘ﾐ 
here where the socks end it may be more ヮヴﾗﾐﾗ┌ﾐIWS ｷa I Sﾗﾐげデ ｴ;┗W デｴW IﾗﾏヮヴWゲゲｷﾗﾐ ゲデﾗIﾆｷﾐｪゲ ﾗﾐくざ 
Informant 4 に Franz and Wann-Hansson 
さSo I tried them up to knee, like pop socks, and when you had them on for a bit, well they give you 
ゲﾗﾏW ヴｷｪｴデ ヮ;ｷﾐが ┞ﾗ┌ ﾆﾐﾗ┘ ┘ｴWヴW デｴW ┗Wｷﾐゲ ゲ┘Wﾉﾉい WｴWﾐ ┞ﾗ┌げ┗W ｴ;S げWﾏ ﾗﾐ ; Hｷデが デｴW┞げヴW ゲﾗ デｷｪｴデ 
ゲデﾗIﾆｷﾐｪゲが ┞ﾗ┌ヴ ｪﾉ;S デﾗ ｪWデ ｴﾗﾏW ;ﾐS ｪWデ げWﾏ ﾗaaくざ Participant 1 に Palfreyman et al 
 
Physical Function 
None of the papers identified that VV prevented specific activities of daily living such as personal 
care or housework; however, they clearly showed that participants experienced limitations in their 
daily lives, for instance being able to participate in leisure activities, walking distances or exercise. 
These restrictions sometimes resulted from physical problems when undertaking certain activities, 
however, some individuals whilst physically able, placed limitations on their activities due to the 
appearance of the VV; this demonstrates a close cross-over between the physical and psychological 
themes. The consequences of the physical impact of VV ┘WヴW HWゲデ SWゲIヴｷHWS ;ゲ けﾐﾗデ HWｷﾐｪ ;HﾉW デﾗ 
ﾉｷ┗W ﾉｷaW a┌ﾉﾉ┞げ ふFヴ;ﾐ┣ ;ﾐS W;ﾐﾐ-Hansson). 
Two papers (Palfreyman et al, Franz and Wann-Hansson) identified that VV could affect the work 
lives of participants; both due to physical and psychological factors. Franz and Wann-Hansson found 
both those that were still working, and those that were now retired, spoke of the struggle of coping 
with symptoms and trying to find relief at work.  
 さI found that they (my legs) get very tired and heavy if I am on my feet for too long, or I have to walk 
デﾗﾗ a;ヴが ゲﾗ ｷデ ┘;ゲ ;ﾉ┘;┞ゲ ;デ デｴW H;Iﾆ ﾗa ﾏ┞ ﾏｷﾐSが デｴ;デ ﾏ┞ ﾉWｪゲ ┘WヴW デﾗﾗ ゲﾗヴW ｷa I SｷS デﾗﾗ ﾏ┌Iｴぐくくざ 
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Psychological Impact 
Psychological impact encompassed sub-themes of worry or anxiety and appearance.  
 
Worry or Anxiety 
In all studies participants expressed worries about deterioration of VV, and the risk of future 
problems such as venous leg ulcers (VLU) or deep vein thrombosis (DVT). This anxiety was 
sometimes rooted in experiences of family or friends.  
さWWﾉﾉが デｴWﾐ デｴW デｴﾗ┌ｪｴデゲ I;ﾏW デｴ;デ ｷデ Iﾗ┌ﾉS HW ゲﾗﾏWデｴｷﾐｪ ﾉｷﾆW デｴ;デ ふ┌ﾉIWヴゲぶ ┘ｴｷIｴ ｷゲ ゲデ;ヴデｷﾐｪげげ 
Informant 4 に Franz and Wann-Hansson 
さI ﾐﾗデｷIWS ; ゲIヴ;デIｴ ;ﾐS I ┘;ゲ ┗Wヴ┞ ┘ﾗヴヴｷWS ;Hﾗ┌デ ﾗヮWﾐｷﾐｪ ゲﾗﾏW skin or something, you know, and 
ヮﾗゲゲｷHﾉ┞ ｪWデデｷﾐｪ ;ﾐ ┌ﾉIWヴくざ Patient 10 に Hudson et al 
けTｴWヴW ┘;ゲ ;ﾉゲﾗ ; aWWﾉｷﾐｪ ;ﾏﾗﾐｪゲデ デｴW ヮ;ヴデｷIｷヮ;ﾐデゲ デｴ;デ ｷa デｴW┞ ｴ;S ゲ┌ヴｪｷI;ﾉ デヴW;デﾏWﾐデ ｷデ ┘ﾗ┌ﾉS 
ヮヴW┗Wﾐデ ;ﾐ┞ a┌ヴデｴWヴ SWデWヴｷﾗヴ;デｷﾗﾐぐくげ  Authors に Palfreyman et al 
 
Appearance 
The psychological effect of VV was also related to appearance; this was reported in all three papers 
and included personal feelings of embarrassment, disgust and feeling self-conscious. There was also 
the impact of the reactions of others, or the worry about a potential negative reaction.  
さI ┘;ゲ ﾃ┌ゲデ ┗Wヴ┞ ;┘;ヴW デｴ;デ ﾏ┞ ﾉWｪゲ ゲｴﾗ┌ﾉSﾐげデ HW ﾉｷﾆW デｴｷゲ ;ﾐS デｴ;デ ｷa デｴW┞ ┘WヴW ﾏﾗヴW ﾐﾗヴﾏ;ﾉ ;ﾐS ﾉWゲゲ 
┌ｪﾉ┞ ;ﾐS ゲ┘ﾗﾉﾉWﾐが デｴWﾐ I ┘ﾗ┌ﾉS aWWﾉ ; Hｷデ ｴ;ヮヮｷWヴくざ Patient 2 に Hudson et al 
さぐ.HWI;┌ゲW I Sﾗﾐげデ ﾉｷﾆW HWｷﾐｪ ゲデ;ヴWS ;デ ;ﾐS ﾉ;┌ｪｴWS ;デ aﾗヴ ゲﾗﾏWデｴｷﾐｪ デｴ;デ I I;ﾐげデ ヮ;ヴデｷI┌ﾉ;ヴﾉ┞ ｴWﾉヮく 
AﾐS デｴW┞げ┗W ┌ヮゲWデ ﾏW ﾏ;ﾐ┞ ; デｷﾏW ┘ｴWﾐ I ┘;ゲ ┞ﾗ┌ﾐｪWヴく TｴW┞ I;ﾉﾉWS ﾏW ; aヴW;ﾆ ;ﾐS デｴｷﾐｪゲ aﾗヴ ｴ;┗ｷﾐｪ 
them. And a lot of people would stare at them and make noises at meざ.    
 Participant 11 に Palfreyman et al 
さIデげゲ ﾏﾗヴW ヮゲ┞IｴﾗﾉﾗｪｷI;ﾉ デｴ;デ I デｴｷﾐﾆ ヮWﾗヮﾉW ;ヴW ゲデ;ヴｷﾐｪ ;デ ﾏ┞ ﾆﾐWWゲざ  
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These issues contributed to negative self-image and self-esteem for participants, both male and 
female. Again there is a link to the theme of adaptation, as the cosmetic impact of VV led to people 
adapting clothing to ensure they covered their VV; in addition they also altered the activities they 
took part in, such as sports and swimming. 
さI ┘;ゲ ┗Wヴ┞ IﾗﾐゲIｷﾗ┌ゲ ﾗa デｴWﾏ ;ﾐS ┘ﾗ┌ﾉSﾐげデ ┘W;ヴ ゲｴﾗヴデゲ ﾗヴ ゲﾆｷヴデゲ aﾗヴ ; ﾉﾗﾐｪ デｷﾏWぐくI ｪ┌Wゲゲ デｴW┞ 
┘WヴWﾐげデ デｴ;デ ﾗH┗ｷﾗ┌ゲ デﾗ ﾗデｴWヴ ヮWﾗヮﾉWが H┌デ デﾗ ﾏW デｴW┞ ┘WヴW Sｷゲｪ┌ゲデｷﾐｪ ;ﾐS I ﾃ┌ゲデ aWﾉデ ﾏﾗヴW Iﾗﾏaﾗヴデ;HﾉW 
ｷﾐ デヴﾗ┌ゲWヴゲぐﾗヴ ;デ ﾉW;ゲデ デｴｷIﾆ デｷｪｴデゲくざ Patient 2 に Hudson et al 
さYﾗ┌ Sﾗ ﾐﾗデ ┘;ﾐデ デﾗ ┘;ﾉﾆ ;ﾏﾗﾐｪ ヮWﾗヮﾉWぐ.and ゲｴﾗ┘ ┞ﾗ┌ヴ ﾉWｪゲざ 
 Informant 3 に Franz and Wann-Hansson 
Palfreyman reported employment was affected for a female participant due to her concerns about 
the appearance of her VV and associated clothing restrictions. 
け“ｴW aWﾉデ デｴ;デ ;ﾐ┞ ﾃﾗH デｴ;デ SｷS ﾐﾗデ ;ﾉﾉﾗ┘ ｴWr to wear trousers meant that she would be unable to take 
┌ヮ ;ﾐ┞ ﾃﾗH ﾗaaWヴくげ Authors に Palfreyman et al 
 
Social Impact 
Impact on social functioning consisted of the sub-themes of restrictions and relationships.    
Restrictions 
All papers highlighted that participants had faced restrictions in their social lives. For some this had 
led to a degree of social isolation due to being unable, or unwilling, to participate in leisure activities 
or exercise.  
さB┌デ W┗Wヴ┞ﾗﾐW I ﾏWWデ ゲ;┞ゲが けC;ﾐ ┞ﾗ┌ IﾗﾏW ;ﾐS W┝WヴIｷゲW ┘ｷデｴ ┌ゲい Iデげゲ ﾏﾗヴW a┌ﾐ ┘ｴWﾐ ┘W ;ヴW ﾏﾗヴW 
ヮWﾗヮﾉWくげ B┌デ I I;ﾐげデく Iげ┗W デヴｷWS デ┘ｷIWく I ｴ;┗W ゲW┗Wヴ;ﾉ aヴｷWﾐSゲ ┘ｴﾗ W┝WヴIｷゲW デ┘ｷIW ; ┘WWﾆくざ 
Informant 2 に Franz and Wann-Hansson 
けIa ;ﾐ┞ ;Iデｷ┗ｷデ┞ ﾏW;ﾐデ デｴ;デ デｴW┞ ふヮ;ヴデｷIｷヮ;ﾐデゲぶ ┘ﾗ┌ﾉS ｴ;┗W デﾗ Wxpose their legs to public view they 
┘ﾗ┌ﾉS IW;ゲW デﾗ HW ｷﾐ┗ﾗﾉ┗WSくげ Authors に Palfreyman et al 
The social impact of VV is further illustrated by Hudson et al, who describe study participants 
reporting the positive effects of surgery in terms of the removal of restrictions, allowing full 
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Relationships 
There was also discussion of the impact on relationships. All papers reported that the negative 
emotions participants had experienced due to the appearance of their VV directly influenced how 
they perceived and interacted with others, both within a wider social context; Hudson et al also 
noted an impact on close personal relationships. 
けOﾐW ヮ;ヴデｷIｷヮ;ﾐデ ヴWヮﾗヴデWS デｴ;デ ｴWヴ ゲ┞ﾏヮデﾗﾏゲ ｷﾐ｡┌WﾐIWS ｴWヴ ｷﾐデWヴ;Iデｷﾗﾐゲ ┘ｷデｴ her husband, leading 
デﾗ デWﾐゲｷﾗﾐゲ ｷﾐ デｴWｷヴ ヴWﾉ;デｷﾗﾐゲｴｷヮくげ Authors に Hudson et al 
さI Sﾗﾐげデ aWWﾉ Iﾗﾏaﾗヴデ;HﾉW I aWWﾉ ﾉｷﾆW ; ﾉﾗデ ﾗa ヮWﾗヮﾉW ゲデ;ヴW ;デ デｴWﾏ ﾗヴ aWWﾉ ヴWヮ┌ﾉゲWS H┞ デｴWﾏくざ  
Participant 11 に Palfreyman et al 
Reasons for Seeking Treatment 
This theme was common to two papers (Palfreyman et al, Hudson et al), however it should be noted 
that exploration of reasons why people seek treatment was a specific objective of Palfreyman et al. 
Both papers identified that the primary reasons for seeking treatment were symptom relief, or to 
prevent worsening of their VV and the possibility of other complications. Expectations for the 
effectiveness of treatment were often found to be unrealistic (Palfreyman et al). Ameliorating the 
cosmetic appearance was a secondary consideration, despite the appearance of VVs being 
commonly reported across the papers as having a distressing psychological and social impact. 
さMﾗヴW デｴ;ﾐ ;ﾐ┞デｴｷﾐｪ ｷゲ デｴ;デ ｷデ ┘ﾗﾐげデ HW ;ゲ ｷデ ｷゲ ﾐﾗ┘が ゲﾗ デｴ;デ デｴW ヮ;ｷﾐ a;Iデﾗヴが デｴW ｴW;┗ｷﾐWゲゲが W┗Wヴ┞デｴｷﾐｪ 
that goes ┘ｷデｴ ｷデ ｴﾗヮWa┌ﾉﾉ┞ ┘ｷﾉﾉ ｴ;┗W ｪﾗﾐWくざ Participant 14 に Palfreyman et al 
さOﾐW ﾗa ﾏ┞ aヴｷWﾐSゲげ ﾏﾗデｴWヴゲ ｴ;S ; ﾉﾗデ ﾗa ヮヴﾗHﾉWﾏゲ ┘ｷデｴ ｴWヴ ┗Wｷﾐゲが I デｴｷﾐﾆ ゲｴW ｴ;S ;ﾐ ┌ﾉIWヴ ;ﾐS I 
ヴWﾏWﾏHWヴ ;ﾉﾉ デｴW デヴﾗ┌HﾉW デｴ;デ I;┌ゲWSく I SｷSﾐげデ ┘;ﾐデ ゲﾗﾏWデｴｷﾐｪ ﾉｷﾆW デｴ;デ ｴ;ヮヮWﾐWS デﾗ ﾏWが ゲﾗ that 
ゲヮ┌ヴヴWS ﾏW ﾗﾐ デﾗ ｪWデ デヴW;デWSくざ Patient 12 に Hudson et al 
Adaptation 
Adaptation was a common theme across all papers, with many different kinds of adaptations 
described. It is important to note that the coping strategies employed to manage symptoms that 
were previously discussed, should be differentiated from the life adaptations considered at this 
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け“デヴ;デWｪｷWゲ aﾗヴ ヴWﾉｷWa ┘WヴW ﾐﾗデ ﾗﾐﾉ┞ ｷﾐゲtrumental measures, such as the use of compression stockings, 
ﾗｷﾐデﾏWﾐデゲが WﾉW┗;デｷﾗﾐ ﾗa デｴW ﾉWｪ ;ﾐS ヮヴﾗヮWヴ ゲｴﾗWゲぐくH┌デ ;ﾉゲﾗ ┘WヴW ｷﾐｴWヴWﾐデ ｷﾐ デｴW ヮﾗ┘Wヴ ﾗa デｴﾗ┌ｪｴデゲが 
;ゲ ┘;ゲ SWゲIヴｷHWS ｷﾐ ﾉW;ヴﾐｷﾐｪ デﾗ ﾉｷ┗W ┘ｷデｴ SｷゲIﾗﾏaﾗヴデ ;ﾐS ;IIWヮデ;ﾐIW ﾗa デｴW SｷゲW;ゲWくげ  
 Authors に Franz and Wann-Hansson 
Overwhelmingly these were life adaptations such as changing activities due to the impact on 
physical function, or coping strategies to deal with symptoms, and adapting work situations.  
さWWﾉﾉが I ｴ;┗W HWWﾐ デｴｷﾐﾆｷﾐｪ ;Hﾗ┌デ デｴW ┘ﾗヴﾆ ゲｷデ┌;デｷﾗﾐぐｷa ｷデ ｷゲ ヮﾗゲゲｷHﾉW デﾗ ヮWヴｴ;ヮゲ Iｴ;ﾐｪW デｴW ﾉWﾐｪデｴ ﾗa 
デｴW ヮWヴｷﾗS ;ﾐS デｴW ﾉWﾐｪデｴ ﾗa ┘ﾗヴﾆｷﾐｪ ｴﾗ┌ヴゲ S┌ヴｷﾐｪ デｴW S;┞ぐくざ  
Informant 9 に Franz and Wann-Hansson 
けWｴWﾐ ｷデ I;ﾏW デﾗ ｷﾐデWヴWゲデゲ ｷﾐ┗ﾗﾉ┗ｷﾐｪ ヮｴ┞ゲｷI;ﾉ ;Iデｷ┗ｷデ┞ ;ﾐS W┝WヴIｷゲWが デｴW ｷﾐaﾗヴﾏ;ﾐデゲ デヴｷWS デﾗ gﾐS 
alternative activities that they could do despite their leg problemsくげ  
Authors に Franz and Wann-Hansson 
Adaptation also appears in relation to the theme of psychological impact, as in all papers there was 
mention of participants adapting what clothing they wore to disguise the appearance of having VV 
and the subsequent negative emotions this caused.   
けM;ﾐ┞ ヮ;ヴデｷIｷヮ;ﾐデゲ ヴWヮﾗヴデWS ゲｴ;ﾏW ヴWｪ;ヴSｷﾐｪ デｴWｷヴ ﾉWｪゲ ;ﾐS デﾗﾗﾆ ﾏW;ゲ┌ヴWゲ デﾗ ;┗ﾗｷS W┝ヮﾗゲｷﾐｪ デｴWﾏ 
ｷﾐ ヮ┌HﾉｷIが ﾗaデWﾐ ;デ Iﾗゲデ デﾗ デｴWｷヴ Iﾗﾏaﾗヴデくげ  
Authors に Hudson et al 
けTｴﾗゲW ┘ｴﾗ ｴ;S HWWﾐ ﾉｷ┗ｷﾐｪ ┘ｷデｴ VV ゲ┞ﾏヮデﾗﾏゲ aﾗヴ ; ﾉﾗﾐｪ デｷﾏW ｴ;S SｷaaWヴWﾐデ ﾏWデｴﾗSゲ デﾗ IﾗﾐIW;ﾉ デｴWｷヴ 
unattractive legs. For example, covering the legs with long pants or a sarong in the summer was one 
┘;┞ ﾗa ｴｷSｷﾐｪ デｴWﾏくげ  
Authors に Franz and Wann-Hansson 
けIﾐ ;SSｷデｷﾗﾐ デﾗ デｴW ｷﾏヮ;Iデ ﾗﾐ デｴWｷヴ ;Iデｷ┗ｷデｷWゲが デｴW IﾗゲﾏWデｷI ;ヮヮW;ヴ;ﾐIW ﾗa デｴWｷヴ ﾉWｪゲ ;ﾉゲﾗ ｷﾐaﾉ┌WﾐIWd the 
デ┞ヮW ﾗa Iﾉﾗデｴｷﾐｪ ┘ﾗヴﾐ H┞ ヮ;ヴデｷIｷヮ;ﾐデゲくげ 
 Authors に Palfreyman et al 
 
DISCUSSION AND SYNTHESIS OF EMERGENT THEMES 
The findings of the review have been discussed with reference to the domains used in PROMs that 
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as PROMs are regularly used to assess the impact of VV on patients, to measure treatment results, 
and to support clinical decision-making.  
The final thematic framework was closely related to the initial framework which emerged from 
analysis and synthesis of PROMs used and validated with a VV population (Aber et al 2017); this may 
lead to suggestions that a deductive, rather than inductive, approach was used. However, themes, 
such as adaptation, did emerge as a result of the analysis and syntheses, which are novel and to date 
not widely described in the existing literature, reflecting the inductive nature of the analysis. 
In our synthesis we identify physical, psychological and social impact, in addition to reasons for 
seeking treatment, and adaptations, as the five key themes that should be addressed in the design 
of future PROMs, and in the provision of care to patients with VV. Table three demonstrates which 
PROMs validated for use with VV patients have domains or items that correspond with the themes 
identified in this review; it should be noted that the VVSymQ was developed solely as a symptom 
report questionnaire. 
The range of physical symptoms reported across the three papers was varied, for example swelling is 
not mentioned by Palfreyman yet appears strongly in the other two included papers; in addition, 
swelling is also a domain in all of the VV specific PROMs (AVVQ, VVSymQ and SQOR-V).  
The degree to which people were bothered by symptoms of VV, such as pain, also varied widely both 
within and across the papers. For some the symptoms appeared to make the participants け;┘;ヴWげ ﾗa 
their VV, whilst for others the pain could be debilitating, resulting in restrictions in their lives and 
requiring the need for active management.  
The diversity and impact of the symptoms reported across the three papers demonstrated that there 
is no definitive list of VV symptoms, and that not all symptoms affect everyone in the same way. 
The subjective nature of symptom experience has implications for the use of PROMs, as specific 
symptoms may not be included in the PROM, for example worries about the appearance of VV; or 
there may be symptoms, such as itching, that are included but that are not typical to all patients.  
There are also implications for clinical decision-making due to the difficulty in measuring symptoms 
of VV, as NICE (2013) guidance for the management of VV states けQoL measures are unlikely to 
reflect severity of disease because of variations in perception of symptomsげ. 
The variety of descriptions of practical day-to-day symptom management across the papers 
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information available to patients about the most effective means of symptom control, and the 
importance of adherence to recommended management options.  
This review also found inconsistency in the use of compression hosiery, as the two papers that 
covered it offered contradictory points. The participants in Franz and Wann-Hansson appeared to 
have more positive experiences of the use of compression than those of Pafreyman. What is not 
clear is whether this differentiation could be due to poor adherence, lack of understanding of the 
benefits of compression, or using incorrectly fitted compression hosiery. 
The sub-theme of physical function related more to physical limitations rather than an absolute 
inability to carry out physical tasks. The lack of clear physical impact may be a contributing factor in 
the reluctance of some NHS trusts in the UK to fund VV surgery, if the assumption is that lack of 
measurable restriction does not merit costly, and not necessarily fully effective, intervention.  
Recurrence of VV after conventional surgical treatment is a common, costly, and complex problem, 
which accounts for over 20% of patients requiring venous surgery (Groenendael et al 2009). Gad et 
al (2012) noted reoccurrence rates of 60% after 5 years; injection sclerotherapy was suggested to 
have a higher than 20% reoccurrence rate (Sheffield Teaching Hospitals 2011). 
The generic PROMs used in the VV population, and the specific instrument AVVQ, both have 
けヮｴ┞ゲｷI;ﾉ a┌ﾐIデｷﾗﾐげ Sﾗﾏ;ｷﾐゲき ｴﾗ┘W┗Wヴが based on the findings reported in the included studies a 
P‘OM Sﾗﾏ;ｷﾐ ヴWﾉ;デWS ﾏﾗヴW デﾗ けヮｴ┞ゲｷI;ﾉ ﾉｷﾏｷデ;デｷﾗﾐゲげが ゲ┌Iｴ ;ゲ デｴ;デ ｷﾐ デｴW SF-36, is perhaps more 
applicable. The SQOR-V includes questions asking to what extent VV affects activities such as 
standing, sitting, walking and using the stairs; this emphasis on extent of limitation rather than 
prevention of carrying out an activity is perhaps more relevant.  
The psychological impact of living with VV appears strongly in this review, with all three papers 
demonstrating a significant impact. Fears of further deterioration and future problems, such as 
developing VLU or DVT, were common in many patients across all papers; this common anxiety has 
HWWﾐ SWゲIヴｷHWS ;ゲ ;ﾐ けW┝;ｪｪWヴ;デWS ゲWﾐゲW ﾗa ヴｷゲﾆ aヴﾗﾏ VVげ H┞ NICE ふヲヰヱンぶ. There appears to be little 
reliable evidence about the proportion of VV that progress to VLU with perhaps only an estimated 3-
6% of people with VV affected (Nelzen 2008). Ensuring patients are well informed about their VV 
condition, and about the risk of other complications, may go some way to mitigating unnecessary 
worry and anxiety.  
Only one VV specific PROM, the SQOR-V, includes domains that would enable patients to report 
psychological, emotional or mental impacts, relevant to the anxiety and worry reported in this 
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The significance of the cosmetic appearance of VV has perhaps historically been trivialised in 
comparison to the impact of symptoms; however, this review found that appearance was a 
significant psychological issue for patients. All three papers highlighted feelings of distress and 
embarrassment felt by patients due to the look of their VV. This was both due to their personal 
perception and the reactions of others.  
Iﾐ デｴW NICE ┗;ゲI┌ﾉ;ヴ ヴWaWヴヴ;ﾉ ｪ┌ｷSWﾉｷﾐWゲ けHﾗS┞-ｷﾏ;ｪW IﾗﾐIWヴﾐゲげ ｷゲ ｷﾐIﾉ┌SWS ;ゲ ;ﾐ ｷﾏヮﾗヴデ;ﾐデ 
measurable outcome of patient-assessed symptoms, ;ﾐS け;ヮヮW;ヴ;ﾐIWげ ｷゲ ｷﾐIﾉ┌SWS ;ゲ ; Sﾗﾏ;ｷﾐ ｷﾐ デｴW 
AVVQ and the SQOR-V; however, it would not be specifically captured by either the VVSymQ or 
generic PROMs. 
Social function was clearly found to be affected in all papers, often leading to varying degrees of 
social isolation. The impact of some VV symptoms resulted in some participants being unable to 
undertake usual leisure activities and hobbies. For others it was down to avoidance due to a 
reluctance to expose their VV.   
In both cases the outcome of social isolation prevented people from living their lives fully, and often 
had implication for personal relationships with partners, friends and family. It would appear that 
there is potentially a close link between social and psychological impact, with social isolation 
contributing to feelings of low mood. Impact of VV on social activities is measured by the SF-36, the 
SQOR-V and the AVVQ.  
Symptom relief rather than the cosmetic appearance was the primary reason for seeking treatment 
in the two papers that explored this theme.  
Existing literature demonstrates that improvement in symptoms is a common, yet potentially 
unrealistic, expectation. Dillon et al (2005) reported that 75% of participants expected VV treatment 
to improve their symptoms, whilst Darvall et al (2009) found that 100% of their participants had 
expected some improvement following treatment yet 20% had unmet expectations.  
If patients feel that their treatment has not met their expectations this is likely to have an impact on 
their QoL. Healthcare professionals need to ensure that all patients are fully informed about 
potential benefits and risks of treatment, including the fact that they might need more than one 
treatment, they may have a reoccurrence, and they may develop new VV in the future.   
Current PROMs do not include a clear process for patients to highlight their reasons for seeking 
treatment, therefore healthcare professionals may find themselves unable to judge whether or not 
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Participants adopted a wide range of adaptations in order to enable them to continue to live their 
lives as fully as possible. This was notable in all aspects pertaining to the impact of VV on QoL, 
physically, psychologically and socially.  
Some adaptations may be characterised as passive, for instance when an individual stops doing 
something because of pain or appearance; whereas other adaptations may be regarded as positive に 
rather than stopping exercise because of appearance or discomfort a new form of exercise is 
adopted.  
The ability of VV patients to positively adapt to their condition and make the adjustments necessary 
to continue working, and otherwise safeguard their health and wellbeing, is one suggested reason 
for the perception of VV as a cosmetic condition (Franz & Wann-Hansson 2015). 
An expectation of successful treatment for patients may be that they would no longer have a need 
to adopt these adaptations, デｴ┌ゲ ﾉW;Sｷﾐｪ デﾗ ; ヴWゲ┌ﾏヮデｷﾗﾐ ﾗa けﾐﾗヴﾏ;ﾉげ ﾉｷaWく  
No available PROM, validated for VV populations, currently exists that would fully capture how 
patients adapt their lives to their condition. The AVVQ and the SQOR-V both ask if clothing choice is 
affected by VV, and the SQOR-V asks if choice of activities is influenced by VV; however, this does 
ﾐﾗデ a┌ﾉﾉ┞ Iﾗ┗Wヴ ｴﾗ┘ ヮ;デｷWﾐデゲ け;S;ヮデげ ﾗヴ Wﾏヮﾉﾗ┞ けIﾗヮｷﾐｪ ゲデヴ;デWｪｷWゲげ デﾗ ﾉｷ┗W デｴWｷヴ ﾉｷ┗Wゲ a┌ﾉﾉ┞く 
 
Further Research - Construction of PROMs 
The content validity of a PROM can be determined by examining the relevance to patients of the 
items included. This can be assessed by considering whether or not items were developed through 
qualitative studies with patients and incorporating qualitative evidence from the literature.  
Accepted guidance suggests that PROMs should be developed using patient generated information 
(FDA 2009). This information is best generated using qualitative research methods, either through 
conducting a primary qualitative study or systematic reviews of existing qualitative literature; both 
of these methods offer greater insight into patient experiences.  
Of the three condition-specific PROMs identified in this paper only one, the VVSymQ, incorporated 
qualitative patient based findings into development. The AVVQ items were based on common 
clinical assessment questions of VV patients, and the SQOR-V ┌ゲWS ; IﾗﾏﾏｷデデWW ﾗa けW┝ヮWヴデゲげ デﾗ 
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An identified aim of the developers of the SQOR-V was in fact to develop a questionnaire that 
considered the patientsげ main concerns yet it appears that they did not consult patients about the 
construction of items. They also concluded th;デ けIﾗﾐデWﾐデ ┗;ﾉｷSｷデ┞ Iﾗ┌ﾉS HW ｷﾐaWヴヴWS ;ゲ ケ┌Wゲデｷﾗﾐゲ ┘WヴW 
created for clarity and completeness by a group of experts iﾐ デｴW aｷWﾉSげ ふG┌W┝ et al 2007); it hard to 
understand how anyone could have more insight than the person who lives with the condition.  
Familiarity with the findings of existing qualitative literature through qualitative reviews, or 
employment of qualitative research methods such as interviews, enables an in-depth understanding 
of the range and severity of symptoms, and resulting impact on QoL, experienced by patients. 
Qualitative methods should be used in the development of PROMs to ensure that they reflect the 
most relevant issues patients face, therefore enhancing the content validity of such measures.  
The findings from this review have been utilized in the development of a new electronic PROM (e-
PAQ-VAS), which is intended to be used with patients with a range of vascular conditions. It 
complements similar reviews that have been conducted with patients who have abdominal aortic 
aneurysms, peripheral arterial disease, carotid arterial disease and venous leg ulcers; and the 
findings from a primary qualitative research study. 
 
Conclusion 
Health-related quality of life, patient-assessed symptoms (including pain, discomfort, body image 
concerns, swelling, aching, and heaviness), and progression have been cited as the most important 
outcomes to identify which people would benefit from a referral to a vascular service (NICE 2013).  
The use of PROMs to gather such information is well established however, as this review has shown, 
those PROMs currently validated for use with patients with VV, both generic and condition-specific, 
ﾏ;┞ ﾐﾗデ I;ヮデ┌ヴW デｴW a┌ﾉﾉ W┝デWﾐデ ﾗa デｴW ｷﾏヮ;Iデ ﾗa VV ﾗﾐ ヮ;デｷWﾐデげゲ QﾗLく 
Healthcare professionals involved in the assessment and care of patients with VV, and those 
involved in planning vascular service provision, need to be as familiar as possible with the lived 
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Relevance to Clinical Practice 
 PROMs data is collected pre and post VV surgery so healthcare professionals should be 
familiar with the instruments used, and have awareness that the questions contained within 
デｴWゲW ｷﾐゲデヴ┌ﾏWﾐデゲ ﾏ;┞ ﾐﾗデ ;II┌ヴ;デWﾉ┞ ヴWaﾉWIデ ヮ;デｷWﾐデゲげ W┝ヮWヴｷWﾐIWゲ ﾗa ﾉｷ┗ｷﾐｪ ┘ｷデｴ VVく As VV 
have a diverse range of symptoms, and the impact can be wide reaching on many different 
aspects of QoL; this can be difficult to capture.  
 The various adaptations patients employ in order to cope with their VV may mask the full 
impact of their condition.  
 Healthcare professionals have a responsibility to ensure patients are aware of both the most 
effective means of symptom control, and the importance of adherence to recommended 
management options. Healthcare professionals should also be properly trained in the fitting 
of compression hosiery in order for patients to potentially receive benefit from them. 
 Patients with VV may have unfounded fears of future problems such as developing VLU or 
DVT; healthcare professionals should ensure patients are well informed about their 
condition, and the risk of other complications, in order to mitigate unnecessary worry and 
anxiety. 
 Healthcare professionals need to ensure that all patients have realistic treatment 
expectations, including potential risks of treatment, such as the fact that they might need 
more than one treatment, they may have a reoccurrence, and they may develop new VV in 
the future.  
 
Limitations 
This paper is subject to limitations both due to the age of one of the included studies, and to the 
small number of studies included overall. Inclusion of a paper 14 years old may limit the relevance of 
its results, and therefore the findings of this review.  Only 3 studies were included in this review 
potentially affecting the representativeness of the thematic findings, and therefore the conclusions 
reached in this paper. As with primary qualitative research, where relatively small samples are the 
norm but selective sampling can continue until data saturation has been achieved, qualitative 
evidence syntheses can benefit from inclusion of and access to, multiple studies so that the 
experience of living with VV can be understood in different contexts and circumstances. The lack of 
available qualitative literature on this subject could suggest that this condition is often overlooked, 
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Table One. Included Studies  
Author and 
Year 





Sweden Exploratory qualitative 

















The essence meant adapting to 
a life with VV, relieving 
discomfort from legs with an 
unfavourable appearance.  
 
Coping with discomfort involved 
dealing with the disease 
emotionally and finding 
strategies that helped to relieve 
symptoms; however, living with 
けヴWヮ┌ﾉゲｷ┗Wげ ﾉWｪゲ ┘;ゲ ゲWWﾐ ;ゲ 
embarrassing, and many found 
the need to hide their condition.  
 




(qualitative section of a 
mixed-methods study 
including an RCT) 
 
Thematic Analysis 
20 (4 from 









Four themes captured  
(1) Negative emotions 
associated with symptoms 
(2) Unpreparedness for the 
surgical process 
(3) Feeling cared for  
(4) Improvements in well-being. 
 
An overarching theme of 
relationships was identified.  
VV had a detrimental impact on 
QoL prior to surgery; post-
surgery QoL improved. 
Palfreyman 
et al (2004)   
 
















Participants attributed a wide 
range of symptoms to their VV, 
and were actively seeking 
treatment with the expectation 
that they would gain symptom 
relief.  
The symptoms attributed to VV 
had a significant negative impact 
on QoL and lifestyle.  
Improving the cosmetic 
appearance of their legs was 
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Symptoms    
Heaviness    
Itching    
Pain     
Swelling X   
Other Symptoms (phlebitis, 
tiredness) 
   
Sleep  X  
Management of symptoms    
Coping Strategies    
Compression  X  
Analgesia  X X 
Elevation    
Physical Function    
Limitations    







    
Worry/Anxiety    
Future Health Problems    
Deterioration    




   
Reactions of Others    
Self-Image/Self-esteem X  X 
 
3. Impact on Social 
Functioning 
    
Restrictions    
Relationships    
 
4. Reasons for 
Seeking Treatment 
    
Symptom Relief   X 
Cosmetic Concerns   X 
Prevent Future Problems   X 
 
5. Adapting to VV 
    
Life Adaptations    
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X   X Appearance2 に including clothing choice 
Appearance/Attractiveness
3
 に including clothing choice 
Physical 
Impact 
X X  X Progression3 
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Sensation
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